Roxane Infringed Vanda's Antipsychotic Patent, Judge Rules
Two of Vanda Pharmaceutical's patents for its schizophrenia drug Fanapt are valid, and Roxane Laboratories Inc. violated one of them when attempting to make a generic, a Delaware federal judge ruled...To view the full article, register now.
Already a subscriber? Click here to view full article